Corleen M. Roche
Chief Financial OfficerMs. Corleen M. Roche serves as Chief Financial Officer at Iovance Biotherapeutics, Inc. since August 6, 2025. She has been the Chief Financial Officer of CG Oncology, Inc. since joining in January 2024 and served as its Secretary since the same date. Ms. Roche served as Chief Financial Officer at Immunome, Inc. since April 2021 until January 2, 2024. She was a corporate finance and business strategist with extensive executive experience in the biopharmaceutical industry. Prior to her most recent role as the U.S. Chief Financial Officer for Biogen Inc. from 2019 until April 2021, she was a Chief Financial Officer at various biopharmaceutical companies including Sandoz from 2015 to 2019. Ms. Roche began her career at PricewaterhouseCoopers and has served as Chief Financial Officer at other companies including IoGenetics, Inc. and the Global Vaccines business unit at Wyeth Pharmaceuticals. Ms. Roche received a B.S. in Accountancy from Villanova University.
Positions
- Company NameIovance Biotherapeutics, Inc.Stock CodeIOVAPositionChief Financial OfficerColleagues
- FGFrederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director
- IDIain D. DukesIndependent Chairman of the Board
- IPIgor P. BilinskyChief Operating Officer
- RKRaj K. PuriChief Regulatory Officer
- DGDaniel G. KirbyChief Commercial Officer
- RDRyan D. MaynardIndependent Director
- MWMichael WeiserIndependent Director
- CYCassian YeeMember of Scientific Advisory Board
